Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The Biden administration believes that including obesity drugs in Medicare coverage will reduce out-of-pocket costs for the ...

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...

Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients reporting extreme side effects. | ITV National News ...

Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by ...

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

World Healthcare Fund (THW) has a high 11.7% dividend yield, ideal for income generation and positioned for future growth in ...

Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.

The number of abortions performed in the U.S. fell slightly in 2022, the year the Supreme Court overruled Roe v. Wade, ...